🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 112 of 857 · Phase 3 first, then by program name

  1. Mirikizumab, Mirikizumab, Mirikizumab

    Eli Lilly Co.

    Crohn's Disease

    phase 3 small molecule active

    1 trial

  2. Mirikizumab, Tirzepatide, to match Tirzepatide, Tirzepatide, Tirzepatide, Mirikizumab, Tirzepatide, Tirzepatide, Tirzepatide

    Eli Lilly Co.

    Obesity or Overweight, Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  3. Mirvetuximab Soravtansine

    AbbVie

    Epithelial Ovarian Cancer

    phase 3 small molecule completed

    1 trial

  4. Mirvetuximab soravtansine plus Bevacizumab

    AbbVie

    Ovarian Cancer

    phase 3 small molecule active

    1 trial

  5. Mitapivat

    Agios Netherlands B.V.

    Non-Transfusion-dependent Alpha-Thalassemia

    phase 3 small molecule active

    1 trial

  6. Mitapivat

    Agios Netherlands B.V.

    Sickle Cell Disease

    phase 3 small molecule active

    2 trials

  7. Mitapivat

    Agios Netherlands B.V.

    Pediatric Pyruvate Kinase Deficiency

    phase 3 small molecule active

    2 trials

  8. Mitapivat Matched Placebo

    Agios Netherlands B.V.

    Transfusion-dependent Alpha-Thalassemia

    phase 3 small molecule active

    1 trial

  9. Mitizodone Phosphate tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Depressive Disorder, Major

    phase 3 small molecule active

    1 trial

  10. Mitomycin-C

    United Therapeutics Europe Ltd

    Corneal Opacity

    phase 3 small molecule active

    1 trial

  11. Mitoxantrone Hydrochloride Liposome

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia (AML)

    phase 3 small molecule active

    1 trial

  12. Mixed salts of a single-entity amphetamine

    Takeda

    Attention Deficit Disorder With Hyperactivity

    phase 3 small molecule completed

    1 trial

  13. Mixed salts of a single-entity amphetamine (ADDERALL XR)

    Takeda

    ADHD

    phase 3 small molecule completed

    1 trial

  14. Modafinil

    Teva Pharma GmbH

    Attention Deficit/Hyperactivity Disorder

    phase 3 small molecule completed

    3 trials

  15. Modafinil

    Teva Pharma GmbH

    Narcolepsy

    phase 3 small molecule completed

    3 trials

  16. Modafinil

    Teva Pharma GmbH

    Sleep Apnea, Obstructive

    phase 3 small molecule completed

    1 trial

  17. Modafinil

    Teva Pharma GmbH

    ADHD

    phase 3 small molecule completed

    1 trial

  18. Modiodal 100 mg tabletten, PLACEBO

    Disc Medicine

    Inflammatory bowel disease, Fatigue

    phase 3 small molecule active

    1 trial

  19. Molnupiravir

    Merck KGaA, Darmstadt, Germany

    Coronavirus Disease (COVID-19)

    phase 3 small molecule active

    2 trials

  20. Molnupiravir Matching placebo tablets, molnupiravir

    Merck Sharp and Dohme

    SARS-CoV-2 (COVID-19) infection

    phase 3 small molecule active

    1 trial

  21. MomeGalen 1 mg/g cutaneous emulsion, Placebo to 0.1% mometasone furoate cutaneous emulsion (active ingredient-free vehicle of mometasone cutaneous emulsion), ECURAL Fettcreme, 1 mg/g Creme

    Lacuna Pharma Pty Ltd

    Plaque psoriasis

    phase 3 small molecule active

    1 trial

  22. Mometasone Furoate Nasal Spray, 50 mcg

    Amneal Pharma Europe Ltd

    Seasonal Allergic Rhinitis

    phase 3 small molecule completed

    1 trial

  23. Mometasonfuroaat Teva 50 microgram/verstuiving, neusspray, suspensie, Mometasonfuroat-ratiopharm® 50 Mikrogramm/Sprühstoß Nasenspray, Suspension, Placebo for benralizumab for clinical trials is a sterile liquid solution presented in an accessorized prefilled syringe (apfs) for subcutaneous injection., Fasenra 30 mg solution for injection in pre-filled syringe

    AstraZeneca AB

    Severe CRSwNP patients with asthma.

    phase 3 small molecule active

    1 trial

  24. Monalizumab, Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung, CETUXIMAB

    AstraZeneca AB

    Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With an Immune Checkpoint Inhibitor

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources